Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

596 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Update on diabetes mellitus: prevention, treatment, and association with oral diseases.
Skamagas M, Breen TL, LeRoith D. Skamagas M, et al. Among authors: leroith d. Oral Dis. 2008 Mar;14(2):105-14. doi: 10.1111/j.1601-0825.2007.01425.x. Oral Dis. 2008. PMID: 18302671 Review.
Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.
Mosa R, Huang L, Li H, Grist M, LeRoith D, Chen C. Mosa R, et al. Among authors: leroith d. Am J Physiol Regul Integr Comp Physiol. 2018 Jan 1;314(1):R71-R83. doi: 10.1152/ajpregu.00157.2017. Epub 2017 Sep 13. Am J Physiol Regul Integr Comp Physiol. 2018. PMID: 28903914 Free PMC article.
Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice.
Kim H, Pennisi PA, Gavrilova O, Pack S, Jou W, Setser-Portas J, East-Palmer J, Tang Y, Manganiello VC, Leroith D. Kim H, et al. Among authors: leroith d. Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1227-36. doi: 10.1152/ajpendo.00344.2005. Am J Physiol Endocrinol Metab. 2006. PMID: 16682489
Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
Pennisi P, Gavrilova O, Setser-Portas J, Jou W, Santopietro S, Clemmons D, Yakar S, LeRoith D. Pennisi P, et al. Among authors: leroith d. Endocrinology. 2006 Jun;147(6):2619-30. doi: 10.1210/en.2005-1556. Epub 2006 Mar 2. Endocrinology. 2006. PMID: 16513827
Loss of glucose homoeostasis: implications of basal glycaemia in type 2 diabetes.
LeRoith D, Smith DO. LeRoith D, et al. Diabetes Obes Metab. 2003 Sep;5(5):285-94. doi: 10.1046/j.1463-1326.2003.00278.x. Diabetes Obes Metab. 2003. PMID: 12940865 Review. No abstract available.
Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.
Kim H, Haluzik M, Asghar Z, Yau D, Joseph JW, Fernandez AM, Reitman ML, Yakar S, Stannard B, Heron-Milhavet L, Wheeler MB, LeRoith D. Kim H, et al. Among authors: leroith d. Diabetes. 2003 Jul;52(7):1770-8. doi: 10.2337/diabetes.52.7.1770. Diabetes. 2003. PMID: 12829645
Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities.
LeRoith D. LeRoith D. Am J Med. 2002 Oct 28;113 Suppl 6A:3S-11S. doi: 10.1016/s0002-9343(02)01276-7. Am J Med. 2002. PMID: 12431757 Review.
Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice.
Ben-Shmuel S, Scheinman EJ, Rashed R, Orr ZS, Gallagher EJ, LeRoith D, Rostoker R. Ben-Shmuel S, et al. Among authors: leroith d. J Endocrinol. 2015 Dec;227(3):143-151. doi: 10.1530/JOE-15-0310. Epub 2015 Sep 17. J Endocrinol. 2015. PMID: 26383532 Free PMC article.
Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes.
Toyoshima Y, Gavrilova O, Yakar S, Jou W, Pack S, Asghar Z, Wheeler MB, LeRoith D. Toyoshima Y, et al. Among authors: leroith d. Endocrinology. 2005 Sep;146(9):4024-35. doi: 10.1210/en.2005-0087. Epub 2005 Jun 9. Endocrinology. 2005. PMID: 15947005
Phloridzin improves hyperglycemia but not hepatic insulin resistance in a transgenic mouse model of type 2 diabetes.
Zhao H, Yakar S, Gavrilova O, Sun H, Zhang Y, Kim H, Setser J, Jou W, LeRoith D. Zhao H, et al. Among authors: leroith d. Diabetes. 2004 Nov;53(11):2901-9. doi: 10.2337/diabetes.53.11.2901. Diabetes. 2004. PMID: 15504971
596 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback